No acute impact of lipid apheresis treatment on free radical scavenging enzyme gene expression in white blood cells

European Journal of Clinical Investigation

Volumn 33, Issue 2, 2003, Pages 134-140

  Schettler, Volker ^a   Krontal, J ^a   Scheel, A ^a   Wieland, E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Free radical scavenging enzymes; LDL apheresis; LightCycler ; Oxygen radicals; White blood cells

Indexed keywords

ANTIOXIDANT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ELONGATION FACTOR 2; ENZYME; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; LIPID; MESSENGER RNA; NITRATE; OXYGEN RADICAL; PRAVASTATIN; SCAVENGER; SIMVASTATIN;

ADULT; ANTIOXIDANT ACTIVITY; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INSTRUMENT; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGE FACTORS; BLOOD COMPONENT REMOVAL; FEMALE; FREE RADICAL SCAVENGERS; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERCHOLESTEROLEMIA; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037325137     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01119.x     Document Type: Article

References (33)

1. Kawano H, Motoyama T, Hirai N, Kugiyama K, Yasue H, Ogawa H. Endothelial dysfunction in hypercholesterolemia is improved by 1-arginine administration: possible role of oxidative stress. Atherosclerosis 2002;161:375-80.
2. Napoli C, Lerman LO. Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc 2001;76:619-31.
3. West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet 1996;348:1339-42.
4. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
6. Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher 2001;5:244-51.
7. Schettler V, Wieland E, Armstrong VW, Kleinoeder T, Grunewald RW, Müller GA. First steps towards the establishment of a German LDL-Apheresis registry. Recommendations for the indication and for quality management. Ther Apher 2002;6:381-3.
8. Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 2000;33 (Suppl.):S85-97.
9. Aviram M. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Antioxid Redox Signal 1999;1:585-94.
10. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
11. Niwa Y, Ozaki Y, Kanoh T, Akamatsu H, Kurisaka M. Role of cytokines, tyrosine kinase, and protein kinase C on production of superoxide and induction of scavenging enzymes in human leukocytes. Clin Immunol Immunopathol 1996;79:303-13.
12. Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991;266:24398-403.
13. Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991;17:271-6.
14. Splettstoesser WD, Schuff-Werner P. Oxidative stress in phagocytes: 'The enemy within'. Microsc Res Tech 2002;57:441-55.
15. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
16. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273-300.
17. Thiery J, Seidel D. Safety and effectiveness of long-term LDL-apheresis in patients at high risk. Curr Opin Lipidol 1998;9:521-6.
18. Schettler V, Methe H, Staschinsky D, Schuff-Werner P, Muller GA, Wieland E. Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis. Ther Apher 1999;3:219-26.
19. Schettler V, Methe H, Schuff-Werner P, Muller GA, Wieland E. Acute effect of H.E.L.P. treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma. Eur J Clin Invest 2000;30:26-32.
20. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954-8, 960, 962.
21. Li XJ, Yan LJ, Zhao BL, Hou JW, Xin WJ. Effects of oxygen radicals on the conformation of sulfhydryl groups on human polymorphonuclear leukocyte membranes. Cell Biol Int Rep 1991;15:667-74.
22. Kolb G, Nolting C, Eckle I, Muller T, Lange H, Havemann K. The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 1991;57:64-8.
23. Lonnemann G, Haubitz M, Schindler R. Hemodialysis-associated induction of cytokines. Blood Purif 1990;8:214-22.
24. Lin YF, Chang DM, Shaio MF, Lu KC, Chyr SH, Li BL, et al. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation. Am J Nephrol 1996;16:293-9.
25. Efe H, Deger O, Kirci D, Karahan SC, Orem A, Calapoglu M. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects. Clin Chim Acta 1999;279:155-65.
26. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999;27:951-65.
27. Ghosh B, Hanevold CD, Dobashi K, Orak JK, Singh I. Tissue differences in antioxidant enzyme gene expression in response to endotoxin. Free Radic Biol Med 1996;21:533-40.
28. Rohrdanz E, Kahl R. Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Radic Biol Med 1998;24:27-38.
29. Yoo HY, Chang MS, Rho HM. The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 1999;274:23887-92.
30. Arnold HH, Heinze H. Treatment of human peripheral lymphocytes with concanavalin A activates expression of glutathione reductase. FEBS Lett 1990;267:189-92.
31. Ji LL. Exercise-induced modulation of antioxidant defense. Ann NY Acad Sci 2002;959:82-92.
32. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-9.
33. Wieland E, Schettler V, Armstrong VW. Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis. Atherosclerosis 2002;162:187-91.